Análysis of data in the Covid-19 study in colombia

Análisis de datos en el estudio del COVID-19 en Colombia

Introduction: in late 2019, the newly emerged SARS-CoV-2, which causes COVID-19, triggered a pandemic that has been associated with more than 500.000 deaths worldwide, as of July 2020. The source of the outbreak was the province of Hubei, China, spreading to other countries. Objective: to analyze the COVID-19 data in Colombia. Methodology: The database including people infected with COVID-19, the individuals who have recovered and those who died from COVID-19 was used for the research, with the information accumulated in Colombia between March 6 and September 21 2020. Results: the measures of central location were estimated as of September 21 2020. The mean for infected cases was 185.757, 25, 122.771,21 for recovered individuals and 6.602,60 for COVID-19-related deaths. The median for infected cases was 49.842,50, 19.624 for recoveries and 1.629,5 for deaths. The mode was 1 for those infected and 0 for those who recovered or died. The minimum of people infected was 1, and the maximum was 770.435. For individuals who recovered the minimum was 0, and the maximum was 640.900. And for those who died, the minimum was 0 and the maximum was 24.397. Conclusions: the incidence and prevalence of the disease will probably continue to rise until a definitive solution to the pandemic caused by COVID-19 is found. It is crucial to study the dynamics of possible infectious disease outbreaks in our country, since this newly emerged disease has shown a rapid contagion rate.

1. Mbow M, Lell B, Jochems SP, Cisse B, Mboup S, Dewals BG, et al. COVID-19 in Africa: Dampening the storm?. Science. 2020;369(6504):624-6. doi: 10.1126/science.abd3902
2. Worobey M, Pekar J, Larsen BB, Nelson MI, Hill V, Joy JB, et al. The emergence of SARS-CoV-2 in Europe and North America. Science. 2020. doi: 10.1101/2020.05.21.109322
3. Maier BF, Brockmann D. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Science. 2020;368(6492):742-6. doi: 10.1126/science.abb4557
4. Colbourn T. COVID-19: extending or relaxing distancing control measures. The Lancet Public health. 2020;5(5):e236-e7. doi: 10.1016/S2468-2667(20)30072-4
5. Lai S, Bogoch I, Ruktanonchai N, Watts A, Lu X, Yang W, et al. Assessing spread risk of Wuhan novel coronavirus within and beyond China, January-April 2020: a travel network-based modelling study. medRxiv. 2020. doi: 10.1101/2020.02.04.20020479
6. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? The Lancet. 2020;395(10231):1225-8. doi: 10.1016/S0140-6736(20)30627-9
7. Ginsburg AS, Van Cleve WC, Thompson MI, English M. Oxygen and pulse oximetry in childhood pneumonia: a survey of healthcare providers in resource-limited settings. Journal of tropical pediatrics. 2012;58(5):389-93. doi: 10.1093/tropej/fmr103
8. Graham BS. Rapid COVID-19 vaccine development. Science. 2020;368(6494):945-6. doi: 10.1126/science.abb8923
9. García Salinero J. Análisis de datos en los estudios epidemiológicos I. Nure Investigación,. 2005;16:1-5.
10. Instituto Nacional de Salud. Coronavirus (CO-VID-19) en Colombia [Internet]. Colombia: Instituto Nacional de Salud; 2020 [cited 2020 agosto]; Available from: https://bit.ly/2UNnOtl.
11. Díaz Pinzón JE. Estimación de la Prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99-102. doiI: 10.31260/REPERTMEDCIR.01217372.1115
12. Díaz Pinzón JE. Proyección del COVID-19 en Colombia. Rev Med. 2020;28(1):11-20.